Investing

First patient dosed in Phase IIb imaging for Brain Mets

by

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Top 5 Canadian Mining Stocks This Week: Tag...

Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due...

$4,000 Gold on the Horizon? Why Smart Money...

Crypto Market Recap: Swiss Central Bank Dismisses Bitcoin...

CoTec Holdings Corp. To Commence Expansion Drilling Program...

RHI: Acqn of royalty over Sandstone Gold Project...

Crypto Market Recap: ARK Invest Calls for Bitcoin...

Crypto Market Recap: $TRUMP Token Soars as President...

Tech 5: Major Players Release Latest Results, Google’s...

Editor’s Picks: Gold Price Touches US$3,500 in Volatile...

Top 5 Canadian Mining Stocks This Week: Tag...

Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due...

$4,000 Gold on the Horizon? Why Smart Money...

Crypto Market Recap: Swiss Central Bank Dismisses Bitcoin...

CoTec Holdings Corp. To Commence Expansion Drilling Program...

RHI: Acqn of royalty over Sandstone Gold Project...

Crypto Market Recap: ARK Invest Calls for Bitcoin...

Crypto Market Recap: $TRUMP Token Soars as President...

Tech 5: Major Players Release Latest Results, Google’s...

Editor’s Picks: Gold Price Touches US$3,500 in Volatile...